Kenneth Bate - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kenneth Bate made 1 insider transaction in Madrigal Pharmaceuticals Inc () with a net sale of 32,489. Other recent insider transactions involving Madrigal Pharmaceuticals Inc () include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 29,800 shares made by Brian Joseph Lynch , and a net sale of 100,000 shares made by Paul A Friedman .

In summary, during the past 3 months, insiders sold 252,542 shares of Madrigal Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 252,542 shares. During the past 18 months, 342,631 shares of Madrigal Pharmaceuticals Inc () were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 82,054 shares.

Madrigal Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kenneth Bate made no insider transaction in Astria Therapeutics Inc (). Other recent insider transactions involving Astria Therapeutics Inc () include a net purchase of 5,204,223 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .

In summary, during the past 3 months, insiders sold 20,000 shares of Astria Therapeutics Inc () in total and bought 2,481,350 shares, with a net purchase of 2,461,350 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc () were sold and 5,204,223 shares were bought by its insiders, resulting in a net purchase of 5,184,223 shares.

Astria Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kenneth Bate made no insider transaction in Vanda Pharmaceuticals Inc (). Other recent insider transactions involving Vanda Pharmaceuticals Inc () include a net sale of 51,638 shares made by Kevin Patrick Moran , a net sale of 56,426 shares made by Timothy Williams , and a net sale of 196,036 shares made by Mihael Hristos Polymeropoulos .

In summary, during the past 3 months, insiders sold 121,098 shares of Vanda Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 121,098 shares. During the past 18 months, 377,072 shares of Vanda Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 377,072 shares.

Vanda Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Kenneth Bate made no insider transaction in Biomarin Pharmaceutical Inc (). Other recent insider transactions involving Biomarin Pharmaceutical Inc () include a net sale of 291,000 shares made by Jean Jacques Bienaime , a net sale of 61,000 shares made by Jeffrey Robert Ajer , and a net sale of 17,380 shares made by Brian Mueller .

In summary, during the past 3 months, insiders sold 139,229 shares of Biomarin Pharmaceutical Inc () in total and bought 0 shares, with a net sale of 139,229 shares. During the past 18 months, 482,233 shares of Biomarin Pharmaceutical Inc () were sold and 3,625 shares were bought by its insiders, resulting in a net sale of 478,608 shares.

Biomarin Pharmaceutical Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.